AHA 24: ALPACAR: Phase 2 Trial of Zerlasiran in High Risk Patients

(5:29)

AHA 24 Late-Breaking Discussion: REALIZE-K

(22:31)

View from the Thoraxcenter: AHA 24 Wrap-Up

(17:38)

Heart Rhythm TV Update: AHA 24 - The OPTION trial for LAAC post AF Ablation

(21:33)

AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy

(10:31)

AHA 24: EMPEROR-Preserved: Diastolic Dysfunction and Empagliflozin in Heart Failure

(4:42)

AHA 24: Amulet IDE: The AMPLATZER Amulet Left Atrial Appendage Occluder Five-Year Results

(6:54)

AHA 24: 3 Trials That Will Change My Practice with Dr Michelle Kittleson

(10:28)

AHA 24: OPTION: LAA Closure with Oral Anticoagulation after AF Ablation

(5:16)

AHA 24: Mavacamten: Real-World Experience from 22 Months of the REMS Program

(7:20)

AHA 24: KRAKEN: Phase 2 Trial of Muvalaplin in High Risk Patients

(3:41)

AHA 24: BROOKLYN: Safety and Efficacy of Obicetrapib in Patients with HeFH

(3:45)

AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity

(17:23)

Swoope - 24 (ft. Aha Gazelle \u0026 Miguel Fresco) (Audio)

(2:49)

Aha

(2:28)

AHA 24 Late-Breaking Discussion: FLOW: Benefits of Semaglutide on CKD by CV Status or Risk

(16:58)

#AHA24 Meeting Wrap Up

(4:56)

View from the Thoraxcenter: What's Hot at AHA 24?

(13:44)